サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1632593

経カテーテル心臓弁の世界市場：市場規模・シェア・動向分析 (用途別・技術別・地域別・セグメント別、2025年～2030年)

Transcatheter Heart Valve Market Size, Share & Trends Analysis Report Application (Transcatheter Aortic Valve, Transcatheter Pulmonary Valve, Transcatheter Mitral Valve), By Technology (Self-Expanded), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 105 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
経カテーテル心臓弁の世界市場：市場規模・シェア・動向分析 (用途別・技術別・地域別・セグメント別、2025年～2030年)
出版日: 2024年12月19日
発行: Grand View Research
ページ情報: 英文 105 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

経カテーテル心臓弁市場の成長と動向：

Grand View Research, Inc.の新しいレポートによると、世界の経カテーテル心臓弁市場規模は、2025年から2030年にかけて15.7%のCAGRを記録し、2030年までに130億米ドルに達すると予測されています。

これらの製品は、通常の弁手術を受けることができない高齢者患者にのみ承認されているため、現在、市場は十分に浸透していません。慢性心血管病の有病率の増加、経済発展の増加、償還シナリオの改善、新技術の迅速な採用などの開発促進要因は、予測期間中に使用率を大幅に改善すると予想されます。

経カテーテル心臓弁市場は、エドワーズ・ライフ・サイエンシズ、メドトロニック、セント・ジュード、ボストン・サイエンティフィックなどの主要企業による研究開発への継続的な投資により、急速に進化しています。SAPIEN 3経カテーテル心臓弁やTRINITY弁のような技術的に先進的な製品は、手術合併症を減らし、患者のコンプライアンスを向上させるように設計されています。例えば、TRINITY TAVIシステムは、患者の安全性と治療成績を損なうことなく、デバイスの容易な回収と再配置を可能にします。

さらに、投資家の関心の高まり、有利な製品パイプライン、迅速な規制当局の承認、潜在的新興企業の買収競争の激化などにより、市場は強い追い風を受けると予想されます。例えば、ゴールドマン・サックスによるヴィーナス・メッドテックの3,700万米ドルの資金調達など、同市場への注目すべき投資があります。市場の動向に合わせて、ボストン・サイエンティフィック、エドワード・ライフ・サイエンス、メドトロニックなどの市場参入企業も、僧帽弁逆流や三尖弁置換の管理用の新製品を開発するために投資を増やしています。

経カテーテル心臓弁市場：分析概要

  • 経カテーテル大動脈弁セグメントは2024年に84.0%の最大市場シェアを占めています。市場は経カテーテル大動脈弁、肺動脈弁、僧帽弁に分類されます。
  • 市場は技術別にバルーン拡張型経カテーテル弁と自己拡張型経カテーテル弁に分類されます。2024年には、自己拡張型経カテーテル弁の分野が66.5%の最大市場シェアを占めています。
  • 北米の経カテーテル心臓弁市場は2024年に48.3%の市場シェアを占め、世界を支配しました。
  • アジア太平洋地域の経カテーテル心臓弁市場は、ライフスタイルの変化、都市化、高齢化により心血管疾患と診断される患者数が増加していることを背景に、大きな成長を遂げています。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 経カテーテル心臓弁市場：変動要因・傾向・範囲

  • 市場連関の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因の分析
  • 経カテーテル心臓弁市場：分析ツール
    • 業界分析：ポーターのファイブフォース分析
    • PESTEL分析

第4章 経カテーテル心臓弁市場：用途別の推定と動向分析

  • 世界の経カテーテル心臓弁市場：用途別のダッシュボード
  • 世界の経カテーテル心臓弁市場：用途別の変動分析
  • 世界の経カテーテル心臓弁市場 (収益ベース、用途別)
  • 経カテーテル大動脈弁
  • 経カテーテル肺動脈弁
  • 経カテーテル僧帽弁

第5章 経カテーテル心臓弁市場：技術別の推定と動向分析

  • 世界の経カテーテル心臓弁市場：技術別のダッシュボード
  • 世界の経カテーテル心臓弁市場：技術別の変動分析
  • 世界の経カテーテル心臓弁市場 (収益ベース、技術別)
  • バルーン拡張型経カテーテル弁
  • 自己拡張型経カテーテル弁

第6章 経カテーテル心臓弁市場：地域別の推定と動向分析 (用途別・技術別)

  • 地域別ダッシュボード
  • 市場規模の予測と動向分析 (2018～2030年)
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 企業/競合の分類
  • ベンダー情勢
    • 主要企業の市場シェア分析 (2024年)
    • Boston Scientific Corporation
    • Bracco Group
    • Braile Biomedica
    • Direct Flow Medical
    • Edward Lifesciences
    • Jenavalve
    • Abbott (St. Jude Medical)
    • Symetis
    • ValveXchange, Inc
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America transcatheter heart valve market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 5 U.S. transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 7 Canada transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 9 Mexico transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 10 Mexico transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Europe transcatheter heart valve market, by region, 2018 - 2030 (USD Million)
  • Table 12 Europe transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 13 Europe transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Germany transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 15 Germany transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 16 UK transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 17 UK transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 18 France transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 19 France transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 20 Italy transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 21 Italy transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 22 Spain transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 23 Spain transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 24 Denmark transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 25 Denmark transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 26 Sweden transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 27 Sweden transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 28 Norway transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 29 Norway transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific transcatheter heart valve market, by region, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 33 China transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 34 China transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 35 Japan transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 36 Japan transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 37 India transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 38 India transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 39 South Korea transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 40 South Korea transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 41 Australia transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 42 Australia transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 43 Thailand transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 44 Thailand transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 45 Latin America transcatheter heart valve market, by region, 2018 - 2030 (USD Million)
  • Table 46 Latin America transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 47 Latin America transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 48 Brazil transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 49 Brazil transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 50 Argentina transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 51 Argentina transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 52 MEA transcatheter heart valve market, by region, 2018 - 2030 (USD Million)
  • Table 53 MEA transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 54 MEA transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 55 South Africa transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 56 South Africa transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 59 UAE transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 60 UAE transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)
  • Table 61 Kuwait transcatheter heart valve market, by application, 2018 - 2030 (USD Million)
  • Table 62 Kuwait transcatheter heart valve market, by technology, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 Transcatheter heart valve market: market outlook
  • Fig. 7 Transcatheter heart valve competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook
  • Fig. 10 Transcatheter heart valve market driver impact
  • Fig. 11 Transcatheter heart valve market restraint impact
  • Fig. 12 Transcatheter heart valve market: Application movement analysis
  • Fig. 13 Transcatheter heart valve market: Application outlook and key takeaways
  • Fig. 14 Transcatheter aortic valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Transcatheter pulmonary valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Transcatheter mitral valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Transcatheter heart valve market: Technology movement analysis
  • Fig. 18 Transcatheter heart valve market: Technology outlook and key takeaways
  • Fig. 19 Balloon expanded transcatheter valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Balloon expanded transcatheter valve market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Global transcatheter heart valve market: Regional movement analysis
  • Fig. 22 Global transcatheter heart valve market: Regional outlook and key takeaways
  • Fig. 23 Global transcatheter heart valve market share and leading players
  • Fig. 24 North America, by country
  • Fig. 25 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. key country dynamics
  • Fig. 27 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Canada key country dynamics
  • Fig. 29 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Mexico key country dynamics
  • Fig. 31 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 UK key country dynamics
  • Fig. 34 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Germany key country dynamics
  • Fig. 36 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 France key country dynamics
  • Fig. 38 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy key country dynamics
  • Fig. 40 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Spain key country dynamics
  • Fig. 42 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark key country dynamics
  • Fig. 44 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Sweden key country dynamics
  • Fig. 46 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Norway key country dynamics
  • Fig. 48 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 China key country dynamics
  • Fig. 51 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Japan key country dynamics
  • Fig. 53 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 India key country dynamics
  • Fig. 55 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Thailand key country dynamics
  • Fig. 57 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Korea key country dynamics
  • Fig. 59 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Australia key country dynamics
  • Fig. 61 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Brazil key country dynamics
  • Fig. 64 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Argentina key country dynamics
  • Fig. 66 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 South Africa key country dynamics
  • Fig. 69 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia key country dynamics
  • Fig. 71 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 UAE key country dynamics
  • Fig. 73 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Kuwait key country dynamics
  • Fig. 75 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Market share of key market players- Transcatheter heart valve market
目次
Product Code: GVR-1-68038-096-5

Transcatheter Heart Valve Market Growth & Trends:

The global transcatheter heart valve market size is expected to reach USD 13.0 billion by 2030, registering a CAGR of 15.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is currently under-penetrated as these products are approved only for geriatric patients who cannot undergo normal valve surgeries. Growth drivers such as increasing prevalence of chronic cardiovascular diseases, increasing economic development, improvement in reimbursement scenario, and faster adoption of new technologies are expected to significantly improve the usage rates over the forecast period.

The transcatheter heart valve market is evolving rapidly due to the continuous investments in R&D by the key market players such as Edwards Life Sciences, Medtronic, St. Jude, and Boston Scientific. The technologically advanced products such as the SAPIEN 3 transcatheter heart valve and the TRINITY Valve are designed to reduce the surgical complications and improve patient compliance. For instance, the TRINITY TAVI system enables easy retrieval and repositioning of the device, without compromising on patient safety and treatment outcomes.

Furthermore, the market is expected to experience strong tailwinds on account of growing investor interest, lucrative product pipeline, faster regulatory approvals, and high competition to acquire potential start-ups. For example, some of the notable investments in the market include the USD 37 million funding of Venus MedTech by Goldman Sachs. In line with the market trends, the other market participants such as Boston Scientific, Edward Life Sciences, and Medtronic have also increased their investments to develop new products for management of mitral valve regurgitation and tricuspid valve replacements.

Transcatheter Heart Valve Market Report Highlights:

  • The transcatheter aortic valve segment holds the largest market share of 84.0% in 2024. The market is divided into transcatheter aortic, pulmonary, and mitral valves.
  • The market is categorized by technology into balloon-expanded transcatheter valves and self-expanded transcatheter valves. In 2024, the self-expanded transcatheter valve segment held the largest market share of 66.5%.
  • The North America transcatheter heart valve market dominated globally with a 48.3% market share in 2024, driven by advanced healthcare infrastructure, high awareness levels, and strong healthcare spending.
  • The Asia Pacific transcatheter heart valve market is experiencing significant growth driven by an increasing number of patients diagnosed with cardiovascular diseases due to changing lifestyles, urbanization, and an aging population.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Technology
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
    • 2.2.2. Technology outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Transcatheter Heart Valve Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising Incidence of Heart Valve Diseases
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Growing preference for minimally invasive procedures
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of treatments
      • 3.2.2.2. Regulatory challenges and approval delays
  • 3.3. Transcatheter Heart Valve Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Transcatheter Heart Valve Market: Application Estimates & Trend Analysis

  • 4.1. Global Transcatheter Heart Valve Market: Application Dashboard
  • 4.2. Global Transcatheter Heart Valve Market: Application Movement Analysis
  • 4.3. Global Transcatheter Heart Valve Market by Application, Revenue
  • 4.4. Transcatheter Aortic Valve
    • 4.4.1. Transcatheter aortic valve market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Transcatheter Pulmonary Valve
    • 4.5.1. Transcatheter pulmonary valve market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Transcatheter Mitral Valve
    • 4.6.1. Transcatheter mitral valve market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Transcatheter Heart Valve Market: Technology Estimates & Trend Analysis

  • 5.1. Global Transcatheter Heart Valve Market: Technology Dashboard
  • 5.2. Global Transcatheter Heart Valve Market: Technology Movement Analysis
  • 5.3. Global Transcatheter Heart Valve Market Estimates and Forecasts, By Technology, Revenue (USD Million)
  • 5.4. Balloon Expanded Transcatheter Valve
    • 5.4.1. Balloon Expanded Transcatheter Valve market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Self-Expanded Transcatheter Valve
    • 5.5.1. Self-Expanded Transcatheter Valve market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Transcatheter Heart Valve Market: Regional Estimates & Trend Analysis by Application and Technology

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Vendor Landscape
    • 7.2.1. Key company market share analysis, 2024
    • 7.2.2. Boston Scientific Corporation
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Bracco Group
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Braile Biomedica
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Direct Flow Medical
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Edward Lifesciences
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Jenavalve
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Abbott (St. Jude Medical)
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Symetis
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. ValveXchange, Inc
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives